pmc logo image
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
Larry Moreland, Ron Gugliotti, Kevin King, Walter Chase, Michael Weisman, Thomas Greco, Rose Fife, Joseph Korn, Robert Simms, John Tesser, Jan Hillson, Jacques Caldwell, Thomas Schnitzer, David Lyons, Ullrich Schwertschlag
Arthritis Res. 2001; 3(4): 247–252. Published online 2001 April 10.
PMCID:
PMC34114
Abstract Full Text PDF–426K
 Is Cited by the Following 2 Articles in this Archive:
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones, Jürgen Scheller, Stefan Rose-John
J Clin Invest. 2011 September 1; 121(9): 3375–3383. Published online 2011 September 1. doi: 10.1172/JCI57158
PMCID:
PMC3163962
Abstract Full Text PDF–460K
The Correlation between Increased Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in Rheumatoid Arthritis Patients
Soo-Jin Chung, Yong-Jin Kwon, Min-Chan Park, Yong-Beom Park, Soo-Kon Lee
Yonsei Med J. 2011 January 1; 52(1): 113–120. Published online 2010 November 30. doi: 10.3349/ymj.2011.52.1.113
PMCID:
PMC3017685
Abstract Full Text PDF–334K
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk